Le Lézard
Classified in: Health, Business
Subjects: SVY, LIC, PSF, STP

Statewide Initiative Led by Ohio Opioid Education Alliance and RecoveryOhio to "Beat the Stigma" Announced


COLUMBUS, Ohio, Nov. 10, 2021 /PRNewswire/ -- The stigma surrounding addiction and mental illness isn't just cruel and misinformed; it prolongs the problem by discouraging people with substance misuse disorder and mental illness from even seeking help.

That's the basis of a new, statewide initiative announced today by the Ohio Opioid Education Alliance in collaboration with RecoveryOhio. The Alliance is the group of community organizations and businesses that launched the "Denial, OH" campaign in 2018. Just as that campaign urged parents to talk to their children about prescription opioid misuse and to understand that anyone's child can be at risk, the effort announced today is aimed at helping Ohioans understand that addiction and mental illness are complex diseases ? partly the result of genetics and other factors, which are largely out of a person's control, and not always moral failings or poor character.

While the Denial, OH campaign focused on central Ohio, the anti-stigma messages will run across the state, starting with 30-second TV ads featuring a fictional game show called "Beat the Stigma!"

The Beat the Stigma campaign will encourage Ohioans to do three things:

The campaign will appear on broadcast television, streaming services, radio, outdoor advertising, and digital and social media. It also will engage communities across Ohio through grassroots activities.

The campaign is the result of months of primary and secondary research with input from Ohio's addiction and mental health experts as well as people with firsthand experience with substance use and mental health disorders.

Messages for Beat the Stigma were developed by Nationwide's national marketing and advertising agency.

The state of Ohio announced its commitment of $9.75 million to the initiative in February, and today's announcement kicks off a campaign by the Opioid Alliance to raise matching funds from businesses and community partners in Ohio.

"Substance use disorder and mental health issues aren't character flaws," Gov. Mike DeWine said. "They're diseases for which people deserve treatment and support on a path to long-term recovery. This campaign is meant to tear down any preconceived notions and reduce stigma to encourage people to seek treatment."

The Alliance is led by the Nationwide Foundation and includes partners across the state.  Nationwide Chief Executive Officer Kirt Walker is appealing to Ohio business leaders to contribute to the campaign.

"The stigmas surrounding addiction and mental health are workplace issues as much as they are battles being waged at home or on our streets," Walker said. "The Denial, OH campaign had a real impact, encouraging parents and guardians to talk to their kids about opioid misuse, and we want to do our part to make the same kind of difference in combatting stigma."

Greta Mayer, chief executive officer of the Mental Health & Recovery Board of Clark, Greene and Madison Counties, said reducing stigma can be as important as clinical treatment for people with addiction and mental illness. "In our field, we often say, 'Treatment works. Recovery happens,' and it's true," Mayer said, "but stigma gets in the way of people seeking treatment and reaching recovery."

Data from a 2019 survey by the federal Substance Abuse and Mental Health Services Administration, combined with Ohio population data, suggests that 1 in 13 Ohioans struggle with addiction. Traumatic experiences such as physical or mental abuse, especially in childhood, increase a person's risk for addiction. Mental illness also is a risk factor for addiction and the two diseases often overlap.

Link to digital media kit with campaign assets here.

SOURCE Ohio Opioid Education Alliance


These press releases may also interest you

at 07:05
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...

at 07:05
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC)...

at 07:00
Dr. Jonathan Lewin, Director of The Center for Musculoskeletal Disorders (CMD) based in Englewood, New Jersey, has become the first surgeon in the state to use the PathKeeper Surgical Spinal Navigation System....

at 07:00
CareRx Corporation ("CareRx" or "the Company")  today announced it will host a conference call, including a slide presentation, to discuss its first quarter 2024 financial results on Friday, May 10, 2024, at 8:30 a.m. Eastern Time (ET). The Company...

at 07:00
...



News published on and distributed by: